Many people discount the recent NEJM study about Echinacea
I think this just shows the amount of distrust that people have for scientific studies. Even when a respected journal like NEJM reports this, it doesn’t really matter. And who can blame them? Patients have been back and forth about Vioxx and hormone replacement therapy with conflicting studies. All one can do is present the (lack of) evidence, make your recommendations, and leave the ultimate decision up to the patient.

Related posts:

1. Breast cancer and hormones
2. Who monitors clinical guidelines?
3. Poll: Testosterone replacement therapy in men with prostate cancer
4. Will to recover
5. My take: Ghost-writing, physician access
6. Criticism of Medicare’s P4P: "Lacking nuance"
7. Merck’s prevailing Vioxx strategy

  Follow on Twitter   Subscribe

Tagged as: patient